|
|
Conservative analysis in CTL epitopes of HBV S protein between B and C genotypes |
CHEN Qingxin1, LI Wenshu1, Chen Zhuoyan1, HE Jiali1, Wang Wenhuan1, Lin Mao1, YE Juxiu2 |
1.Institute of Microbiology and Immunology, Wenzhou Medical University, Wenzhou 325035, China; 2.School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou 325035, China |
|
Cite this article: |
CHEN Qingxin,LI Wenshu,Chen Zhuoyan, et al. Conservative analysis in CTL epitopes of HBV S protein between B and C genotypes[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2019, 49(4): 253-257.
|
|
Abstract Objective: To analyze the conservative property in CTL epitopes of HBV large S proteins and figure out the stable epitopes between B and C genotypes. Methods: A pair of primers for S gene of HBV was designed, the S gene amplified by PCR and construed into pIRES vector. According to large S protein from B and C genotypes of HBV, specific CTL epitopes in large S protein of HBV had been analyzed and screened by BIMAS, NetMHC and SYFPEITHI. Conservative property analysis was made by comparing candidate CTL epitopes with large S protein database of HBV B and C genotypes conducted by BLAST. Results: HBV S gene was cloned into pIRES expression vector successfully. Seventeen CTL epitopes of large S protein were screened according to scores of BIMAS, NetMHC or SYFPEITHI. High conservative property in B and C genotypes of HBV (>80%) was showed in 6 CTL epitopes which were not identified now. 17 CTL epitopes, including 6 identified CTL epitopes, were not conservative in B and C genotypes of HBV. Conclusion: The specific CTL epitopes of large S protein of HBV show high differences between B and C genotypes. Six CTL epitopes of HBV large S protein are obtained for further immunological studies.
|
Received: 21 October 2018
|
|
|
|
|
[1] 李晓东, 徐东平, 成军, 等. 中国人群流行的乙型肝炎病毒特异性CTL表位特点分析[J]. 解放军医学杂志, 2006(8): 775-777.
[2] 顾锡炳, 杨小娟, 王栋, 等. 慢性乙型肝炎患者HBV特异性CTL、非特异性CTL的变化和意义[J]. 免疫学杂志, 2010, 26(5): 442-443, 451.
[3] SHEN X, JIN J, DING Y, et al. Novel immunodominant epitopes derived from MAGE-A3 and its significance in serological diagnosis of gastric cancer[J]. J Cancer Res Clin Oncol, 2013, 139(9): 1529-1538.
[4] 哈明昊, 佘会元, 吴建秋, 等. 乙型肝炎病毒包膜区和核心区CTL抗原表位变异对感染慢性化及疾病转归的影响[J]. 实用肝脏病杂志, 2015, 18(6): 581-584.
[5] 薛皓, 张颖倩, 薛付忠, 等. 现有乙型肝炎多表位疫苗在中国人群中的理论免疫效果评价[J]. 山东大学学报(医学版),
2009, 47(10): 114-117,121.
[6] 任玉林, 张宇, 邱立鹏, 等. 新型HLA-A2限制的B,C型HBV特异性CTL表位的筛选及鉴定[J]. 科学通报, 2010, 55(30): 2915-2926.
[7] CHEN X, TANG Y, ZHANG Y, et al. Tapasin modification on the intracellular epitope HBcAg18-27 enhances HBV-specific CTL immune response and inhibits hepatitis B virus replication in vivo[J]. Lab Invest, 2014, 94(5): 478-490.
[8] LIU Q, ZHENG Y, YU Y, et al. Identification of HLA-A*0201-restricted CD8+ T-cell epitope C64-72 from hepatitis B virus core protein[J]. Int Immunopharmacol, 2012, 13(2): 141-147.
[9] 顾锡炳, 杨小娟, 王栋, 等. 慢性乙型肝炎患者血清HBV DNA水平与HBV特异性CTL、非特异性CTL、Th1、Th2的关系[J]. 实用医学杂志, 2011, 27(8): 1424-1426.
[10] 范振平, 王福生, 徐东平, 等. 乙型肝炎患者HBcAg特异性细胞毒性T细胞的检测及其与临床疾病状态的关系[J]. 中华医学杂志, 2004, 84(24): 21-24.
[11] 张晓晨, 李玉敏, 李家亿, 等. 乙型肝炎病毒前S1抗原关键表位基因分型及其与全长前S1抗原基因型的相关性[J]. 中华肝脏病杂志, 2018, 26(5): 371-376. |
|
|
|